What's in BioNTech SE's pipeline?

BioNTech SE has 5 drugs in our index: 5 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with BioNTech SE's portfolio?

Top competitors by shared drug class: Pfizer, Green Cross Corporation, Novartis Pharmaceuticals, Pfizer Inc., CanSino Biologics Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/biontech.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-14 · How we verify

BioNTech SE — Portfolio Competitive Intelligence Brief

BioNTech SE (BNTX) pipeline: 5 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

BNTX (NASDAQ) 5 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Assorted Licensed Hand Sanitizer Grape 01	Licensed Influenza Vaccine 3	marketed	Vaccine	Influenza virus hemagglutinin protein	Immunology
Investigational COVID-19 Vaccine	Investigational COVID-19 Vaccine	marketed	Not specified	Not specified	Infectious Disease
Influenza	Influenza and COVID-19 Combination A	marketed	Non-Standardized Plant Allergenic Extract [EPC]	SARS-CoV-2 spike protein and influenza hemagglutinin protein	Immunology
Influenza	Influenza and COVID-19 Combination B	marketed	Non-Standardized Plant Allergenic Extract [EPC]	Not specified	Infectious Disease
Licensed Influenza Vaccine 2	Licensed Influenza Vaccine 2	marketed	Vaccine	Not specified	Infectious Disease

Therapeutic area mix

Infectious Disease · 3
Immunology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Pfizer · 3 shared drug classes
Green Cross Corporation · 2 shared drug classes
Novartis Pharmaceuticals · 2 shared drug classes
Pfizer Inc. · 2 shared drug classes
CanSino Biologics Inc. · 1 shared drug class
Centre for Infectious Disease Research in Zambia · 1 shared drug class
Beijing Minhai Biotechnology Co., Ltd · 1 shared drug class
Boryung Pharmaceutical Co., Ltd · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for BioNTech SE:

Cite this brief

Drug Landscape (2026). BioNTech SE — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/biontech. Accessed 2026-05-14.